PPHM Company info 08/25/2014 14:32:18 $PPHM It would make

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
PPHM Company info 08/25/2014 14:32:18 $PPHM
It would make sense since the partnership page is completely gone...no need for partnership when some BP buying them outright. You can't ask for a bigger partner than Roche, right? GLTAL.
Quote:
I'm not trying to start rumours, but rather trying to stop rumours by the many that say PPHM is not in any current partnering negotiations.

My post only implies Bayer was interested as recently as 2nd quarter 2014 and in no way does it actually say anything has been decided by either party.


thanks for the post. As of now, we can officially link possible partnership interests to Bayer as of 2Q 2014 and with Abbott back in 2012 per witness testimony on legal documents submitted as part of the Peregrine vs. CSM lawsuit. I'd also like to add that neither side ever denied those claims that Peregrine was about to sign a partnership with Abbott back in that timeframe. We can also add "Ambit Biosciences" per Peregrine employee profiles as another collaboration to the mix... heck, that has been ongoing for about 8 months...

Patterns have formed and still forming and I've just about ran out of colored string connecting all these dots.



PPHM Stock Message Board http://investorshangout.com/Peregrine-Pharmac...PHM-55152/

LOL, the Duke Report...BTW, I feel something is up, too. Whether it's good or bad, we'll soon find out (or, it could be a dud as in nothing occurs). GL.
All this talk about a proxy...maybe Roche will be in there...maybe not.
Judging by todays price action and volume, I'd say something HUGE is right around the corner. The Duke paper?
Never did, never will... Unless she proves us wrong... Until then, nope.
Bungler or anyone else have an update on this: This was on May 29th from Bungler: It was about the betabodies

"This is a "non-final" rejection, meaning that the Applicant has the right to respond and/or amend the claims; therefore Dr. Fussey needs to formulate a response to the examiner's position that it would have been allegedly "obvious" to combine disclosures of three separate documents to arrive at the claimed invention. My initial impression is that this examiner has not received sufficient training to understand that he simply cannot disagree with an affidavit submitted to traverse the proposed combination of prior art. Unless there is EVIDENCE in the record that contradicts Dr. Thorpe's Affidavit that was filed in October 2012, the examiner MUST accept it. Let's see how Dr. Fussey responds"
So you believe this "sierra", eh?
Yup and that's why we're stuck at $300mm market cap.... Because that's what Roche wants to pay for us.... Could you imagine?.. NOT!!
As I said you are on top of this. I don't doubt that many on this board will reconsider even holding shares of PPHM. Where were you in 2006 when I bought this bummer of a stock, anyhow?
Pretty funny stuff. Maybe the catalyst list should be expanded to Bayer buying pphm because they mentioned them in 2004, and Peregrine the asset mgmt software company secretly buying tickets to have partner meetings.
Right on time..."sierra's" Roche pump today:

Roche Buyout Negotiations Of PPHM To Be Confirmed In Upcoming Official Roche Press Release Predicts Sierra World Equity Review
A final Countdown?
Thanks for clearly that up. I was about to buy more shares but not now. Thanks.
It does not mean Bayer was looking at pphm in 2014, just that thw page was auto rebuilt then. They are called CMS systems, no one sis around writing html/xml pages. Just like the pphm partner tab eing gone - meaningless.
We've been on the down low for so long I can't get up.
Maybe their trying to keep it on the down low. ; )

LOL

wook
With the pending RS, partnership, CA, CSM, curing cancer and now no TICKETS..........!

it's no wonder we have only traded 200K today...............!
No, I am guessing they do communicate with the Investigator and are on friendly terms. However, they publicly state they have no control and in terms of a lawsuit, I would think this would go a long way in protecting them. Good luck trying to prove differently.

The fact that they issue a PR and include a quote is nothing more than relaying based on what the quote says this is what we think is happening (legally speaking).

IMO someone would have a tough time holding them accountable for the quote. If a company says we plan to make a lot of money selling widgets this year so loan us money based on the following. They show quotes from 10 companies that buy widgets from them saying they plan on buying a lot of widgets due to projected business the rest of the year and the business doesn't materialize, I don't think the lender has a case unless he can show their was definite intent to mislead. Tough to prove. Of course I don't know it all. Just a little bit.

I am sure there is a conspiracy there somewhere. Anybody can sue anybody. There is always a fool who is willing to make the attorneys money.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan Faces Investor Class Action After Stock Tumbles

Updated Category News Views 15

Shake-Up at Gildan: Investors Take Legal Action Gildan Activewear Inc. (NYSE:GIL) got themselves in hot water, folks. They've landed on the wrong side of an investor class action lawsuit after claims of shady business tactics sent their stock plummeting like a rock in June. We're talking about an 18.75% nosedive here. That's not just a slip—it's a fall worth wearing a...

Continue Reading
Ad Council Expands Board, Taps Meta Exec as Vice Chair

Updated Category News Views 0

An Unexpected Shuffle at the Ad Council Alright, folks, let's talk shop about the recent shake-up in the nonprofit realm. The Ad Council, which has been around longer than some of the giants controlling today's marketing landscapes, just plumped up its Board of Directors with 23 new heavy-hitters. We're talking about leaders from every nook and cranny of the...

Continue Reading
North Fork Mono Casino Opens: A $750 Million Bet

Updated Category News Views 40

A New Spin in Madera Cue the fanfare, folks! The North Fork Mono Casino just threw open its doors earlier than expected today, marking a hefty $750 million wager right in the heart of California's Central Valley. It's a big deal managed by Station Casinos, part of Red Rock Resorts, Inc. (NASDAQ: RRR)—teaming up with the North Fork Rancheria of Mono Indians for a...

Continue Reading
Epson Innovates Order Pickup at Florida Food Hall

Updated Category News Views 126

Changing the Food Hall Game Innovation isn't just a Silicon Valley buzzword; it found its place at the Central Park St. Pete Food Hall in Florida. These guys have figured out the magic formula to streamline multi-vendor dining with Epson's point-of-sale label printers. We're talking about keeping guests from playing musical chairs with food orders, folks. It's a...

Continue Reading
Altea Targets US Market, Appoints Rodrick VP Amid Expansion

Updated Category News Views 58

Wading into the murky waters of U.S. healthcare insurance isn't for the faint of heart, but Altea's making its move. Backed by MISSION, they're banking on a niche strategy by tapping veteran Justin Rodrick as Vice President. Their tactic? Aim squarely at the under-served segment of small to mid-sized medical and healthcare facilities. The play's bold, and if Rodrick's got...

Continue Reading
Medical Device Manufacturing: $135B Market by 2031

Updated Category News Views 89

Skyrocketing Demand in Medical Device Manufacturing You're looking at a market that's gearing up to hit a whopping $135.47 billion by 2031. That's a big leap from its $85.59 billion stature in 2026, showing a strong 9.6% compound annual growth rate (CAGR). Now, if that doesn't get your investor rollercoaster senses tingling, I don't know what will. Key Growth Drivers The...

Continue Reading
Posterity Health Boosts Network to Six New Markets

Updated Category News Views 132

Expansion at Breakneck Speed Just like that, we've got Posterity Health making power moves across the country, staking claim in six major markets. Denver's very own fertility platform is on a roll, and this ain't just any rollout. We're talking partnerships like confetti in the air, dotting spots from the sunny Cali shores of Orange County to the bustling streets of...

Continue Reading
Counterfeits in Aerospace: Industry Tackles Supply Risks

Updated Category News Views 105

The Trouble with Counterfeit Parts in Aerospace Ah, aerospace—the domain where milliseconds matter, and materials must be tougher than a New York steelworker's boots. But guess what's throwing a wrench in the works? Counterfeit parts. That's right, the sector's latest buzzkill is as sneaky as a penny stock scam, and it's about time the industry's heavyweights had a...

Continue Reading
Meta's Bold Move: $25B Offering and New Stocks

Updated Category News Views 62

Meta's New Financial Adventure Well, when Meta talks money, you better believe the market listens. This time, they’ve got a whopping pair of offerings on the table—one for depositary shares and another for their Class A common stock. Meta, under the ticker NASDAQ:META, isn't holding back, with a $25 billion upsized offering that's bound to rattle some cages. A Deeper...

Continue Reading
Cracking the Last-Mile 'Fragmentation Tax' Challenge

Updated Category News Views 12

Tackling Last-Mile Delivery Woes It's like trying to put a square peg in a round hole. That's what last-mile delivery feels like right now with the burden we're seeing in EMEA—costs shooting up by 9% just this past year. Anyone in logistics knows that red ink doesn't just dry up on its own. According to FarEye, 96% of companies are coughing up more dough per delivery,...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Exelon's Earnings: Insights and Future Potential

Updated Category News Views 142

Understanding Exelon's Upcoming Earnings Report Exelon Corporation (NASDAQ: EXC) is preparing to reveal its quarterly earnings in the near future. Investors are keenly awaiting the results, as they want insights into the company’s performance and projections for the following period. Analysts predict that Exelon will report an earnings per share (EPS) of $0.39,...

Continue Reading
Vallourec Invites Warrant Holders to General Meeting

Updated Category News Views 157

Vallourec Invites Warrant Holders to General Meeting Vallourec has announced a significant upcoming event for its warrant holders, also known as BSA. This meeting is set to take place soon, providing an opportunity for holders to engage with the company's future decisions. Details of the Meeting The general meeting will occur at the Vallourec headquarters, where the...

Continue Reading
Investigation Initiated for Molina Healthcare Investors Following Financial Reports

Updated Category News Views 246

Pomerantz LLP Begins Investigation on Behalf of Molina Investors Pomerantz LLP has embarked on an investigation focusing on the interests of investors in Molina Healthcare, Inc. (NYSE: MOH). This inquiry aims to ascertain whether Molina and certain executives may have been involved in any unlawful activities related to securities fraud. Key Financial Findings and Investor...

Continue Reading
How SymphonyAI's Insights Drive E-commerce Growth in Grocery

Updated Category News Views 159

Unlocking E-commerce Potential in Grocery Retail In a transformative announcement, SymphonyAI, a leader in predictive and generative AI SaaS products for enterprises, has unveiled groundbreaking insights from its annual grocery e-commerce study. This research indicates a noteworthy 8% growth opportunity for retailers leveraging AI-driven strategies in their connected...

Continue Reading
Exploring the Impact of Honda and Nissan's Potential Merger

Updated Category News Views 408

Honda and Nissan's Strategic Talks Honda (NYSE:HMC) and Nissan (OTC:NSANY) have entered discussions that may lead to a potential merger, a significant move reflecting the shifting landscape of Japan's automotive industry. As these two giants explore deeper ties, it marks a notable strategy to face the competition posed by Tesla and various Chinese car manufacturers....

Continue Reading